US OptionsDetailed Quotes
ALNY241220P250000
- 6.41
- +0.61+10.52%
15min DelayClose Dec 3 16:00 ET
6.80High6.39Low
6.39Open5.80Pre Close4 Volume881 Open Interest250.00Strike Price2.60KTurnover38.16%IV3.28%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier17DDays to Expiry6.41Extrinsic Value100Contract SizeAmericanOptions Type-0.4397Delta0.0192Gamma35.47Leverage Ratio-0.2326Theta-0.0484Rho-15.59Eff Leverage0.2133Vega
Alnylam Pharmaceuticals Stock Discussion
Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024 | ALNY Stock News
ALNY BUY ALERT 🚨 DRUG NEWS MULTIPLE PRICE TARGET RAISES
No comment yet